Home/Filings/4/0001209191-12-018572
4//SEC Filing

Arbeit Robert D. 4

Accession 0001209191-12-018572

CIK 0000861838other

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 5:46 PM ET

Size

5.8 KB

Accession

0001209191-12-018572

Insider Transaction Report

Form 4
Period: 2012-03-13
Arbeit Robert D.
VP Clinical Development
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-03-13+9,37584,375 total
    Exercise: $1.16Exp: 2021-11-28Common Stock (9,375 underlying)
Footnotes (1)
  • [F1]On December 5, 2011, the reporting person was granted an option to purchase up to an aggregate of 150,000 shares of common stock. Half of the shares subject to such option are subject to satisfaction of performance vesting criteria. On March 13, 2012, certain performance vesting criteria were met with respect to 9,375 of such shares, of which 2,343 shares vested on March 13, 2012 and the remaining 7,032 of which will vest in three equal annual installments beginning on March 13, 2013.

Issuer

IDERA PHARMACEUTICALS, INC.

CIK 0000861838

Entity typeother

Related Parties

1
  • filerCIK 0001488206

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 5:46 PM ET
Size
5.8 KB